Coya Therapeutics Stock Forward View - Simple Moving Average
| COYA Stock | 4.87 0.13 2.74% |
Coya Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Coya Therapeutics stock prices and determine the direction of Coya Therapeutics Common's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of Coya Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time, the RSI of Coya Therapeutics' share price is approaching 46 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Coya Therapeutics, making its price go up or down. Momentum 46
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.39) | EPS Estimate Current Year (1.22) | EPS Estimate Next Year (1.63) | Wall Street Target Price 16.0714 | EPS Estimate Current Quarter (0.30) |
Using Coya Therapeutics hype-based prediction, you can estimate the value of Coya Therapeutics Common from the perspective of Coya Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Coya Therapeutics using Coya Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Coya using crowd psychology based on the activity and movement of Coya Therapeutics' stock price.
Coya Therapeutics Short Interest
A significant increase or decrease in Coya Therapeutics' short interest from the previous month could be a good indicator of investor sentiment towards Coya. Short interest can provide insight into the potential direction of Coya Therapeutics stock and how bullish or bearish investors feel about the market overall.
200 Day MA 5.8876 | Short Percent 0.0428 | Short Ratio 2.8 | Shares Short Prior Month 665.7 K | 50 Day MA 5.4474 |
Coya Relative Strength Index
The Simple Moving Average forecasted value of Coya Therapeutics Common on the next trading day is expected to be 4.80 with a mean absolute deviation of 0.15 and the sum of the absolute errors of 8.88.Coya Therapeutics Common Hype to Price Pattern
Investor biases related to Coya Therapeutics' public news can be used to forecast risks associated with an investment in Coya. The trend in average sentiment can be used to explain how an investor holding Coya can time the market purely based on public headlines and social activities around Coya Therapeutics Common. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Coya Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Coya Therapeutics.
Coya Therapeutics Implied Volatility | 1.99 |
Coya Therapeutics' implied volatility exposes the market's sentiment of Coya Therapeutics Common stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Coya Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Coya Therapeutics stock will not fluctuate a lot when Coya Therapeutics' options are near their expiration.
The Simple Moving Average forecasted value of Coya Therapeutics Common on the next trading day is expected to be 4.80 with a mean absolute deviation of 0.15 and the sum of the absolute errors of 8.88. Coya Therapeutics after-hype prediction price | USD 4.74 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Coya Therapeutics to cross-verify your projections. Open Interest Against 2026-03-20 Coya Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Coya Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Coya Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Coya Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Coya Therapeutics' open interest, investors have to compare it to Coya Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Coya Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Coya. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Coya Therapeutics Additional Predictive Modules
Most predictive techniques to examine Coya price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Coya using various technical indicators. When you analyze Coya charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Coya Therapeutics Simple Moving Average Price Forecast For the 4th of February
Given 90 days horizon, the Simple Moving Average forecasted value of Coya Therapeutics Common on the next trading day is expected to be 4.80 with a mean absolute deviation of 0.15, mean absolute percentage error of 0.04, and the sum of the absolute errors of 8.88.Please note that although there have been many attempts to predict Coya Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Coya Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Coya Therapeutics Stock Forecast Pattern
| Backtest Coya Therapeutics | Coya Therapeutics Price Prediction | Research Analysis |
Coya Therapeutics Forecasted Value
In the context of forecasting Coya Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Coya Therapeutics' downside and upside margins for the forecasting period are 1.44 and 8.17, respectively. We have considered Coya Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Coya Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Coya Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.1607 |
| Bias | Arithmetic mean of the errors | 0.0238 |
| MAD | Mean absolute deviation | 0.1504 |
| MAPE | Mean absolute percentage error | 0.0284 |
| SAE | Sum of the absolute errors | 8.875 |
Predictive Modules for Coya Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Coya Therapeutics Common. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Coya Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Coya Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Coya Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Coya Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Coya Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Coya Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Coya Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Coya Therapeutics' historical news coverage. Coya Therapeutics' after-hype downside and upside margins for the prediction period are 1.38 and 8.10, respectively. We have considered Coya Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Coya Therapeutics is slightly risky at this time. Analysis and calculation of next after-hype price of Coya Therapeutics Common is based on 3 months time horizon.
Coya Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Coya Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Coya Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Coya Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.26 | 3.36 | 0.00 | 0.00 | 4 Events / Month | 7 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
4.87 | 4.74 | 0.00 |
|
Coya Therapeutics Hype Timeline
Coya Therapeutics Common is currently traded for 4.87. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Coya is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at -0.26%. %. The volatility of related hype on Coya Therapeutics is about 42000.0%, with the expected price after the next announcement by competition of 4.87. About 25.0% of the company shares are held by institutions such as insurance companies. The book value of Coya Therapeutics was currently reported as 1.63. The company recorded a loss per share of 1.11. Coya Therapeutics Common had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 4 days. Check out Historical Fundamental Analysis of Coya Therapeutics to cross-verify your projections.Coya Therapeutics Related Hype Analysis
Having access to credible news sources related to Coya Therapeutics' direct competition is more important than ever and may enhance your ability to predict Coya Therapeutics' future price movements. Getting to know how Coya Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Coya Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| IMMX | Immix Biopharma | 0.16 | 8 per month | 4.21 | 0.14 | 14.88 | (8.41) | 28.79 | |
| CLNN | Clene Inc | (0.04) | 11 per month | 0.00 | (0.13) | 9.73 | (15.07) | 47.42 | |
| MGNX | MacroGenics | 0.03 | 8 per month | 3.89 | (0.01) | 6.83 | (6.25) | 24.44 | |
| ORMP | Oramed Pharmaceuticals | 0.15 | 9 per month | 1.90 | 0.19 | 6.98 | (3.49) | 17.67 | |
| OVID | Ovid Therapeutics | (0.01) | 7 per month | 4.82 | 0.02 | 9.20 | (9.09) | 36.13 | |
| CNTX | Context Therapeutics | (0.11) | 8 per month | 3.43 | 0.22 | 9.59 | (6.09) | 20.53 | |
| PLRX | Pliant Therapeutics | 0.02 | 7 per month | 0.00 | (0.17) | 4.58 | (6.71) | 22.72 | |
| WHWK | Whitehawk Therapeutics | (0.08) | 6 per month | 3.78 | 0.07 | 6.98 | (6.67) | 21.49 | |
| STTK | Shattuck Labs | (0.06) | 7 per month | 2.84 | 0.22 | 6.42 | (4.82) | 27.07 | |
| ZNTL | Zentalis Pharmaceuticals Llc | 0.02 | 8 per month | 4.31 | 0.1 | 17.36 | (9.54) | 48.58 |
Other Forecasting Options for Coya Therapeutics
For every potential investor in Coya, whether a beginner or expert, Coya Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Coya Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Coya. Basic forecasting techniques help filter out the noise by identifying Coya Therapeutics' price trends.Coya Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Coya Therapeutics stock to make a market-neutral strategy. Peer analysis of Coya Therapeutics could also be used in its relative valuation, which is a method of valuing Coya Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Coya Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Coya Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Coya Therapeutics shares will generate the highest return on investment. By undertsting and applying Coya Therapeutics stock market strength indicators, traders can identify Coya Therapeutics Common entry and exit signals to maximize returns.
Coya Therapeutics Risk Indicators
The analysis of Coya Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Coya Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting coya stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.61 | |||
| Standard Deviation | 3.4 | |||
| Variance | 11.55 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Coya Therapeutics
The number of cover stories for Coya Therapeutics depends on current market conditions and Coya Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Coya Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Coya Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Coya Therapeutics Short Properties
Coya Therapeutics' future price predictability will typically decrease when Coya Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Coya Therapeutics Common often depends not only on the future outlook of the potential Coya Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Coya Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 15.2 M | |
| Cash And Short Term Investments | 38.3 M |
Check out Historical Fundamental Analysis of Coya Therapeutics to cross-verify your projections. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Coya Therapeutics. Projected growth potential of Coya fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Coya Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (1.11) | Revenue Per Share | Quarterly Revenue Growth (0.95) | Return On Assets | Return On Equity |
The market value of Coya Therapeutics Common is measured differently than its book value, which is the value of Coya that is recorded on the company's balance sheet. Investors also form their own opinion of Coya Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Coya Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Coya Therapeutics' market value can be influenced by many factors that don't directly affect Coya Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Coya Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Coya Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Coya Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.